Arcutis Biotherapeutics, Inc. shares sold by Howard Welgus
- 4728 shares to be sold
- Aggregate market value: $127,325.04
- Date of sale: 10/15/2026
Howard G. Welgus, reporting
ARQT
Arcutis Biotherapeutics, Inc. SEC filings
Every EDGAR filing for Arcutis Biotherapeutics, Inc. (ARQT), newest first, with AI summaries and stories.
- Ticker
- ARQT
- CIK
- 1787306
- Latest filing
- 3d
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE ROUTINESCHEDULE 13G/AArcutis Biotherapeutics, Inc.ARQTLIVE Arcutis Biotherapeutics, Inc. (ARQT) reported
- BlackRock, Inc. owns 14.1% of common stock
- 17,751,435 shares beneficially owned
- BlackRock Advisors, LLC is a subsidiary
BlackRock, Inc.
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE Masaru Matsuda, insider filing for ARQT
Masaru Matsuda, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE Howard G. Welgus, insider filing for ARQT
Howard G. Welgus, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Larry Todd Edwards, planned sale of ARQT shares
Larry Todd Edwards, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Howard G. Welgus, planned sale of ARQT shares
Howard G. Welgus, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE Masaru Matsuda, insider filing for ARQT
Masaru Matsuda, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Masaru Matsuda, planned sale of ARQT shares
Masaru Matsuda, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE Terrie Curran, insider filing for ARQT
Terrie Curran, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Terrie Curran, planned sale of ARQT shares
Terrie Curran, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE Terrie Curran, insider filing for ARQT
Terrie Curran, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE Patrick Burnett, insider filing for ARQT
Patrick Burnett, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Terrie Curran, planned sale of ARQT shares
Terrie Curran, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE Howard G. Welgus, insider filing for ARQT
Howard G. Welgus, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Patrick Burnett, planned sale of ARQT shares
Patrick Burnett, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Howard G. Welgus, planned sale of ARQT shares
Howard G. Welgus, reporting
ROUTINESCHEDULE 13GArcutis Biotherapeutics, Inc.ARQTLIVE Ownership stake disclosure by Polar Capital Holdings Plc
Polar Capital Holdings Plc, filed by
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE Patrick Burnett, insider filing for ARQT
Patrick Burnett, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Patrick Burnett, planned sale of ARQT shares
Patrick Burnett, reporting
ROUTINESCHEDULE 13GArcutis Biotherapeutics, Inc.ARQTLIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE 3 insider filings
Patrick Burnett, insider filing for ARQT
Show all 3
- 4Insider filing for ARQT
- 4Insider filing for ARQT
- 4Insider filing for ARQT
Patrick Burnett, reporting
NOTABLE10-QArcutis Biotherapeutics, Inc.ARQTLIVE ROUTINE8-KArcutis Biotherapeutics, Inc.ARQTLIVE ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE 3 Form 144 notices
Masaru Matsuda, planned sale of ARQT shares
Show all 3
- 144Planned insider sale of ARQT shares
- 144Planned insider sale of ARQT shares
- 144Planned insider sale of ARQT shares
Masaru Matsuda, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE 3 insider filings
Christopher Peetz, insider filing for ARQT
Show all 3
- 4Insider filing for ARQT
- 3New insider at ARQT
- 4Insider filing for ARQT
Christopher Peetz, reporting
ROUTINE8-KArcutis Biotherapeutics, Inc.ARQTLIVE ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Howard G. Welgus, planned sale of ARQT shares
Howard G. Welgus, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE 2 insider filings
Sue-Jean Lin, insider filing for ARQT
Show all 2
- 4Insider filing for ARQT
- 4Insider filing for ARQT
Sue-jean Lin, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE Howard G. Welgus, planned sale of ARQT shares
Howard G. Welgus, reporting
ROUTINE144Arcutis Biotherapeutics, Inc.ARQTLIVE 2 Form 144 notices
Sue-Jean Lin, planned sale of ARQT shares
Show all 2
- 144Planned insider sale of ARQT shares
- 144Planned insider sale of ARQT shares
Sue-jean Lin, reporting
ROUTINE4/AArcutis Biotherapeutics, Inc.ARQTLIVE Patrick J Heron, insider filing for ARQT (amended)
Patrick J Heron, reporting
ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE 8 insider filings
Howard G. Welgus, insider filing for ARQT
Show all 8
- 4Insider filing for ARQT
- 4Insider filing for ARQT
- 4Insider filing for ARQT
- 4Insider filing for ARQT
- 4Insider filing for ARQT
- 4Insider filing for ARQT
- 4Insider filing for ARQT
- 4Insider filing for ARQT
Howard G. Welgus, reporting
ROUTINE8-KArcutis Biotherapeutics, Inc.ARQTLIVE ROUTINE4Arcutis Biotherapeutics, Inc.ARQTLIVE 2 insider filings
Latha Vairavan, insider filing for ARQT
Show all 2
- 4Insider filing for ARQT
- 4Insider filing for ARQT
Latha Vairavan, reporting